23.90
price up icon1.79%   0.42
after-market After Hours: 23.90
loading
Pacira Biosciences Inc stock is traded at $23.90, with a volume of 1.05M. It is up +1.79% in the last 24 hours and down -7.51% over the past month. Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
See More
Previous Close:
$23.48
Open:
$23.51
24h Volume:
1.05M
Relative Volume:
1.24
Market Cap:
$1.13B
Revenue:
$681.75M
Net Income/Loss:
$70.47M
P/E Ratio:
16.48
EPS:
1.45
Net Cash Flow:
$173.19M
1W Performance:
-3.40%
1M Performance:
-7.51%
6M Performance:
+26.86%
1Y Performance:
-16.46%
1-Day Range:
Value
$23.41
$24.23
1-Week Range:
Value
$23.24
$25.16
52-Week Range:
Value
$11.16
$29.33

Pacira Biosciences Inc Stock (PCRX) Company Profile

Name
Name
Pacira Biosciences Inc
Name
Phone
650-242-8052
Name
Address
2000 SIERRA POINT PARKWAY, BRISBANE, NJ
Name
Employee
790
Name
Twitter
Name
Next Earnings Date
2024-11-06
Name
Latest SEC Filings
Name
PCRX's Discussions on Twitter

Compare PCRX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
PCRX
Pacira Biosciences Inc
23.90 1.13B 681.75M 70.47M 173.19M 1.45
Drug Manufacturers - Specialty & Generic icon
RGC
Regencell Bioscience Holdings Ltd
17.04 303.95B 0 -5.87M -767.30K -0.45
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
155.95 74.39B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.37 48.97B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.46 47.39B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.76 20.17B 16.54B -1.64B 749.00M -1.45

Pacira Biosciences Inc Stock (PCRX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-30-25 Upgrade Truist Sell → Hold
Aug-13-24 Downgrade Truist Buy → Sell
Aug-12-24 Downgrade JP Morgan Overweight → Underweight
Aug-12-24 Downgrade Piper Sandler Overweight → Neutral
Aug-12-24 Downgrade RBC Capital Mkts Outperform → Sector Perform
Aug-12-24 Downgrade Raymond James Outperform → Mkt Perform
Jul-03-24 Downgrade Barclays Overweight → Equal Weight
Mar-07-24 Resumed JP Morgan Overweight
Dec-20-23 Initiated Raymond James Outperform
Aug-03-23 Upgrade TD Cowen Market Perform → Outperform
Jan-31-23 Resumed Wedbush Outperform
Oct-21-22 Resumed Jefferies Buy
Jan-03-22 Resumed JP Morgan Overweight
Jul-26-21 Upgrade JP Morgan Neutral → Overweight
Apr-21-21 Resumed JP Morgan Neutral
Apr-09-21 Initiated Berenberg Buy
Apr-07-21 Resumed RBC Capital Mkts Outperform
Feb-11-21 Downgrade Northland Capital Outperform → Market Perform
Jan-21-21 Downgrade SVB Leerink Outperform → Mkt Perform
Sep-21-20 Upgrade Northland Capital Market Perform → Outperform
Jul-06-20 Reiterated Needham Buy
May-27-20 Initiated Guggenheim Neutral
Apr-07-20 Initiated Northland Capital Outperform
Mar-20-20 Upgrade SVB Leerink Mkt Perform → Outperform
Feb-24-20 Reiterated H.C. Wainwright Buy
Jan-24-20 Initiated SunTrust Buy
Jan-23-20 Initiated SunTrust Buy
Nov-06-19 Initiated BTIG Research Buy
Jun-11-19 Initiated Barclays Overweight
May-06-19 Upgrade Mizuho Underperform → Neutral
May-02-19 Upgrade Stifel Sell → Hold
Feb-01-19 Downgrade Mizuho Neutral → Underperform
Aug-06-18 Downgrade BofA/Merrill Buy → Neutral
Apr-09-18 Reiterated H.C. Wainwright Buy
Mar-21-18 Reiterated Mizuho Neutral
Feb-16-18 Downgrade Needham Buy → Hold
Jan-19-18 Initiated Seaport Global Securities Buy
Jan-04-18 Reiterated Canaccord Genuity Buy
Jan-03-18 Initiated Leerink Partners Mkt Perform
View All

Pacira Biosciences Inc Stock (PCRX) Latest News

pulisher
Jun 18, 2025

Is the Options Market Predicting a Spike in Pacira BioSciences Stock? - TradingView

Jun 18, 2025
pulisher
Jun 18, 2025

Investors in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) Should Contact the Shareholders Foundation in Connection with Lawsuit - Newswire :) Press Release Distribution

Jun 18, 2025
pulisher
Jun 18, 2025

Pacira BioSciences Debuts Inspiring New Film Highlighting - GlobeNewswire

Jun 18, 2025
pulisher
Jun 18, 2025

Pacira BioSciences Debuts Inspiring New Film Highlighting One Patient’s Journey to Pain Relief and Innovation in Care at BIO 2025 - GlobeNewswire Inc.

Jun 18, 2025
pulisher
Jun 18, 2025

PACIRA ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire

Jun 18, 2025
pulisher
Jun 17, 2025

PACIRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Pacira BioSciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - Business Upturn

Jun 17, 2025
pulisher
Jun 17, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Pacira BioSciences, Inc. (PCRX) Shareholders to Inquire about Securities Investigation - ACCESS Newswire

Jun 17, 2025
pulisher
Jun 16, 2025

When the Price of (PCRX) Talks, People Listen - news.stocktradersdaily.com

Jun 16, 2025
pulisher
Jun 15, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Pacira BioSciences, Inc. (PCRX) And Encourages Shareholders to Connect - ACCESS Newswire

Jun 15, 2025
pulisher
Jun 15, 2025

Rhumbline Advisers Sells 9,754 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World

Jun 15, 2025
pulisher
Jun 14, 2025

GAMMA Investing LLC Grows Stock Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

Pacira Pharmaceuticals Stockholders Approve Amended Incentive Plan - TipRanks

Jun 13, 2025
pulisher
Jun 12, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Pacira BioSciences, Inc. (PCRX) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Jun 12, 2025
pulisher
Jun 12, 2025

Have Pacira BioSciences Insiders Been Selling Stock? - simplywall.st

Jun 12, 2025
pulisher
Jun 11, 2025

Pacira (PCRX) Shares Promising Long-Term Data for Osteoarthritis Gene Therapy | PCRX Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Pacira BioSciences Unveils Three-Year Clinical Data - GlobeNewswire

Jun 11, 2025
pulisher
Jun 11, 2025

Pacira BioSciences Unveils Three-Year Clinical Data Following a Single Local Administration of Investigational Gene Therapy, PCRX-201, in Patients with Moderate-to-Severe Osteoarthritis of the Knee - Yahoo Finance

Jun 11, 2025
pulisher
Jun 11, 2025

Pacira BioSciences (NASDAQ:PCRX) Seems To Use Debt Quite Sensibly - simplywall.st

Jun 11, 2025
pulisher
Jun 10, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pacira BioSciences, Inc. (PCRX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

Jun 10, 2025
pulisher
Jun 08, 2025

Pacira BioSciences, Inc. (PCRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Jun 08, 2025
pulisher
Jun 08, 2025

Pacira BioSciences (NASDAQ:PCRX) Raised to Buy at Wall Street Zen - Defense World

Jun 08, 2025
pulisher
Jun 08, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 21,781 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World

Jun 08, 2025
pulisher
Jun 05, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Pacira BioSciences, Inc. (PCRX) And Encourages Investors to Connect - ACCESS Newswire

Jun 05, 2025
pulisher
Jun 05, 2025

Pacira (PCRX) BioSciences Grants Inducement Awards to New Employ - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jun 05, 2025
pulisher
Jun 05, 2025

Pacira Expands Team: 19 New Hires Receive $1.8M in Stock Awards and Options - Stock Titan

Jun 05, 2025
pulisher
Jun 02, 2025

Two Sigma Investments LP Purchases 45,222 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World

Jun 02, 2025
pulisher
Jun 02, 2025

Q3 EPS Estimate for Pacira BioSciences Raised by Analyst - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

Pacira BioSciences, Inc. (PCRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Jun 01, 2025
pulisher
May 30, 2025

Pacira BioSciences, Inc. (NASDAQ:PCRX) Shares Acquired by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World

May 30, 2025
pulisher
May 30, 2025

Pacira BioSciences, Inc. (NASDAQ:PCRX) Shares Purchased by ProShare Advisors LLC - Defense World

May 30, 2025
pulisher
May 29, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pacira BioSciences, Inc. (PCRX) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

May 29, 2025
pulisher
May 29, 2025

Pacira BioSciences’s First Quarter 2025 Misses Estimates - Orthopedics This Week

May 29, 2025
pulisher
May 28, 2025

Pacira BioSciences, Inc. (NASDAQ:PCRX) Shares Purchased by Nuveen Asset Management LLC - Defense World

May 28, 2025
pulisher
May 26, 2025

Grabar Law Office Investigates Claims on Behalf of - GlobeNewswire

May 26, 2025
pulisher
May 25, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Pacira BioSciences, Inc. (PCRX) And Encourages Investors to Reach Out - ACCESS Newswire

May 25, 2025
pulisher
May 24, 2025

Trading (PCRX) With Integrated Risk Controls - news.stocktradersdaily.com

May 24, 2025
pulisher
May 24, 2025

Ameriprise Financial Inc. Acquires 194,597 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World

May 24, 2025
pulisher
May 24, 2025

Pacira BioSciences, Inc. (NASDAQ:PCRX) Receives Average Recommendation of “Hold” from Brokerages - Defense World

May 24, 2025
pulisher
May 22, 2025

Pacira BioSciences (NASDAQ:PCRX) adds US$78m to market cap in the past 7 days, though investors from three years ago are still down 57% - Yahoo Finance

May 22, 2025
pulisher
May 21, 2025

Pacira at RBC Conference: Strategic Growth and Gene Therapy Focus - Investing.com

May 21, 2025
pulisher
May 18, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Pacira BioSciences, Inc. (PCRA) Shareholders to Inquire about Securities Investigation - ACCESS Newswire

May 18, 2025
pulisher
May 18, 2025

2025-05-18 | Bronstein, Gewirtz & Grossman, LLC Encourages Pacira BioSciences, Inc. (PCRA) Shareholders to Inquire about Securities Investigation | Press Release - Stockhouse

May 18, 2025
pulisher
May 18, 2025

The Manufacturers Life Insurance Company Sells 458 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World

May 18, 2025
pulisher
May 17, 2025

Pacira BioSciences, Inc. (NASDAQ:PCRX) Shares Sold by Comerica Bank - Defense World

May 17, 2025
pulisher
May 17, 2025

Northern Trust Corp Buys 145,205 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World

May 17, 2025
pulisher
May 15, 2025

PCRX Investors Have Opportunity to Lead Pacira BioSciences, Inc. Securities Fraud Lawsuit - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Pacira (PCRX) Reports Promising Data on PCRX-201 Gene Therapy fo - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Pacira (PCRX) Reports Promising Data on PCRX-201 Gene Therapy for Knee Osteoarthritis | PCRX Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Pacira BioSciences Presents New Data on the Effects of Clinical Immunogenicity on Locally Administered PCRX-201 in Patients with Moderate to Severe Osteoarthritis of the Knee - The Manila Times

May 15, 2025
pulisher
May 15, 2025

Pacira BioSciences Presents New Data on the Effects of - GlobeNewswire

May 15, 2025

Pacira Biosciences Inc Stock (PCRX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Pacira Biosciences Inc Stock (PCRX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
WILLIAMS KRISTEN
Chief Administrative Officer
Jun 04 '25
Sale
26.24
14,376
377,226
161,574
$14.28
price down icon 0.07%
$8.93
price down icon 0.89%
$125.69
price up icon 0.22%
$287.35
price up icon 1.08%
drug_manufacturers_specialty_generic RDY
$15.03
price down icon 0.27%
$16.76
price up icon 0.00%
Cap:     |  Volume (24h):